Literature DB >> 22053858

Gender, HIV status, and psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Mariana Lopes1, Mark Olfson, Judith Rabkin, Deborah S Hasin, Analucía A Alegría, Keng-Han Lin, Bridget F Grant, Carlos Blanco.   

Abstract

OBJECTIVE: More than 30 years after the onset of the human immunodeficiency virus (HIV) epidemic, there is no information on the prevalence of psychiatric disorders among HIV-positive individuals in the general population. We sought to compare the prevalence of 12-month psychiatric disorders among HIV-positive and HIV-negative adults stratified by sex and to examine the differential increase in risk of a psychiatric disorder as a function of the interaction of sex and HIV status.
METHOD: Face-to-face interviews were conducted between 2004 and 2005 with participants in the National Epidemiologic Survey on Alcohol and Related Conditions Wave 2, a large nationally representative sample of US adults (34,653). The diagnostic interview used was the Alcohol Use Disorder and Associated Disabilities Interview Schedule-DSM-IV Version.
RESULTS: When compared with their HIV-negative same-sex counterparts, HIV-positive men were more likely to have any mood disorder (odds ratio [OR] = 6.10; 95% confidence interval [CI], 2.99-12.44), major depressive disorder/dysthymia (OR = 3.77; 95% CI, 1.16-12.27), any anxiety disorder (OR = 4.02; 95% CI, 2.12-7.64), and any personality disorder (OR = 2.50; 95% CI, 1.34-4.67). In relation to their same-sex HIV-negative counterparts, the effect of HIV status on the odds of any mood disorder (OR = 7.17; 95% CI, 2.52-20.41), any anxiety disorder (OR = 3.45; 95% CI, 1.27-9.38), and any personality disorder (OR = 2.66; 95% CI, 1.16-6.10) was significantly greater for men than women.
CONCLUSIONS: HIV status was significantly more strongly associated with psychiatric disorders in men than in women. HIV-positive men had a higher prevalence than HIV-negative men of most psychiatric disorders. By contrast, HIV-positive women were not significantly more likely than HIV-negative women to have psychiatric disorders. © Copyright 2012 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22053858      PMCID: PMC3816377          DOI: 10.4088/JCP.10m06304

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  84 in total

1.  Effects of combined counseling and case management to reduce HIV risk behaviors among Hispanic drug injectors in Puerto Rico: a randomized controlled study.

Authors:  Rafaela R Robles; Juan C Reyes; Héctor M Colón; Hardeo Sahai; C Amalia Marrero; Tomás D Matos; José M Calderón; Elizabeth W Shepard
Journal:  J Subst Abuse Treat       Date:  2004-09

2.  Self-reported HIV-related risk behaviors in acute psychiatric inpatients: a pilot study.

Authors:  M H Sacks; S Perry; R Graver; R Shindledecker; S Hall
Journal:  Hosp Community Psychiatry       Date:  1990-11

Review 3.  Psychosis associated with HIV infection.

Authors:  S Halstead; M Riccio; P Harlow; R Oretti; C Thompson
Journal:  Br J Psychiatry       Date:  1988-11       Impact factor: 9.319

4.  The natural history of alcohol abuse: implications for definitions of alcohol use disorders.

Authors:  D S Hasin; B Grant; J Endicott
Journal:  Am J Psychiatry       Date:  1990-11       Impact factor: 18.112

5.  Reducing HIV-risk behavior among adults receiving outpatient psychiatric treatment: results from a randomized controlled trial.

Authors:  Michael P Carey; Kate B Carey; Stephen A Maisto; Christopher M Gordon; Kerstin E E Schroder; Peter A Vanable
Journal:  J Consult Clin Psychol       Date:  2004-04

6.  Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Bridget F Grant; Frederick S Stinson; Deborah A Dawson; S Patricia Chou; Mary C Dufour; Wilson Compton; Roger P Pickering; Kenneth Kaplan
Journal:  Arch Gen Psychiatry       Date:  2004-08

7.  Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women.

Authors:  Judith A Cook; Dennis Grey; Jane Burke; Mardge H Cohen; Alejandra C Gurtman; Jean L Richardson; Tracey E Wilson; Mary A Young; Nancy A Hessol
Journal:  Am J Public Health       Date:  2004-07       Impact factor: 9.308

8.  Co-occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Bridget F Grant; Frederick S Stinson; Deborah A Dawson; S Patricia Chou; W June Ruan; Roger P Pickering
Journal:  Arch Gen Psychiatry       Date:  2004-04

9.  Schizophrenia and sexual functioning.

Authors:  J Verhulst; B Schneidman
Journal:  Hosp Community Psychiatry       Date:  1981-04

10.  Prevalence, correlates, and disability of personality disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions.

Authors:  Bridget F Grant; Deborah S Hasin; Frederick S Stinson; Deborah A Dawson; S Patricia Chou; W June Ruan; Roger P Pickering
Journal:  J Clin Psychiatry       Date:  2004-07       Impact factor: 4.384

View more
  40 in total

1.  Substance abuse, violence, and HIV/AIDS (SAVA) syndemic effects on viral suppression among HIV positive women of color.

Authors:  Kristen A Sullivan; Lynne C Messer; E Byrd Quinlivan
Journal:  AIDS Patient Care STDS       Date:  2014-11-14       Impact factor: 5.078

2.  A Systematic Review of Personality Disorders and Health Outcomes.

Authors:  Katherine L Dixon-Gordon; Diana J Whalen; Brianne K Layden; Alexander L Chapman
Journal:  Can Psychol       Date:  2015-10-15

3.  HIV-1 proteins accelerate HPA axis habituation in female rats.

Authors:  Leonidas Panagiotakopoulos; Sean Kelly; Gretchen N Neigh
Journal:  Physiol Behav       Date:  2015-02-07

4.  Prevalence and correlates of HIV testing and HIV-positive status in the US: Results from the National Epidemiological Survey on Alcohol and Related Conditions III (NESARC-III).

Authors:  Carlos Blanco; Melanie M Wall; Wilson M Compton; Shoshana Kahana; Tianshu Feng; Tulshi Saha; Jennifer C Elliott; H Irene Hall; Bridget F Grant
Journal:  J Psychiatr Res       Date:  2018-08-03       Impact factor: 4.791

5.  Mental Health and Substance Use Among Patients in a North Carolina HIV Clinic.

Authors:  Linda M Skalski; Melissa H Watt; Jessica C MacFarlane; Rae Jean Proeschold-Bell; Jason E Stout; Kathleen J Sikkema
Journal:  N C Med J       Date:  2015 Jul-Aug

6.  Implementing electronic substance use disorder and depression and anxiety screening and behavioral interventions in primary care clinics serving people with HIV: Protocol for the Promoting Access to Care Engagement (PACE) trial.

Authors:  Derek D Satre; Alexandra N Anderson; Amy S Leibowitz; Tory Levine-Hall; Sally Slome; Jason Flamm; C Bradley Hare; Jennifer McNeely; Constance M Weisner; Michael A Horberg; Paul Volberding; Michael J Silverberg
Journal:  Contemp Clin Trials       Date:  2019-08-22       Impact factor: 2.226

7.  Psychiatric disorders and adherence to antiretroviral therapy among a population of HIV-infected adults in Nigeria.

Authors:  Olurotimi Adejumo; Bibilola Oladeji; Onoja Akpa; Kay Malee; Olusegun Baiyewu; Adesola Ogunniyi; Scott Evans; Baiba Berzins; Babafemi Taiwo
Journal:  Int J STD AIDS       Date:  2015-09-18       Impact factor: 1.359

8.  Chronic HIV-1 Tat and HIV reduce Rbfox3/NeuN: evidence for sex-related effects.

Authors:  Yun Kyung Hahn; Ruturaj R Masvekar; Ruqiang Xu; Kurt F Hauser; Pamela E Knapp
Journal:  Curr HIV Res       Date:  2015       Impact factor: 1.581

9.  Factors associated with treatment initiation for psychiatric and substance use disorders among persons with HIV.

Authors:  Derek D Satre; Gerald N DeLorenze; Charles P Quesenberry; Ailin Tsai; Constance Weisner
Journal:  Psychiatr Serv       Date:  2013-08-01       Impact factor: 3.084

10.  Association of Marijuana Use with Changes in Cognitive Processing Speed and Flexibility for 17 Years in HIV-Seropositive and HIV-Seronegative Men.

Authors:  Chukwuemeka N Okafor; Michael W Plankey; Michael Li; Xinguang Chen; Pamela J Surkan; Steve Shoptaw; Eileen Martin; Ronald Cohen; Ned Sacktor; Robert L Cook
Journal:  Subst Use Misuse       Date:  2019-01-30       Impact factor: 2.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.